Logo-jnp
J Nephropathol. 2022;11(1): e7.
doi: 10.34172/jnp.2022.07

Scopus ID: 85119589586
  Abstract View: 3040
  PDF Download: 793

Original Article

Prevalence and clinical presentation of COVID-19 infection in hemodialysis patients

Azra Kenarkoohi 1 ORCID logo, Maryam Maleki 2* ORCID logo, Bahareh Ghiasi 3* ORCID logo, Elham Bastani 4 ORCID logo, Iraj Pakzad 1 ORCID logo, Mahtab Bonyadi 5 ORCID logo, Amir Abdoli 6 ORCID logo, Shahab Falahi 7 ORCID logo

1 Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran
2 Department of Physiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran
3 Department of Nephrology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran, Iran
4 Department of Internal Medicine, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran
5 Clinical Research Development, Mostafa Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran
6 Department of Parasitology and Mycology, School of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran
7 Zoonotic Diseases Research Center, Ilam Ilam University of Medical Sciences, Ilam, Iran
*Corresponding Authors: Email: maleki-m@medilam.ac.ir; *Corresponding authors: Maryam Maleki, Email; Maryammaleki777@yahoo.com, maleki-m@medilam.ac.ir and Bahareh Ghiasi, Email: bahar55gh@yahoo.com, ghiasi-b@medilam.ac.ir, Email:

Abstract

Introduction: Hemodialysis (HD) patients are at increased risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Objectives: The aim of this study was to evaluate the prevalence and clinical symptoms of SARS-CoV-2 infection in HD patients.

Patients and Methods: This is a single-center study conducted at HD center, in Ilam, Iran. The study was included 87 HD patients to be tested. SARS-CoV-2 infection was diagnosed with confirmed test by rRT-PCR (real-time reverse transcription polymerase chain reaction) assay.

Results: Around 35.63% of HD patients were diagnosed as COVID-19 infection; most of them were male (74.4%). Dyspnea (58.1%) and cough (45.2%) were the most common symptoms among HD cases with SARS-CoV-2 infection. Diabetes (16.1%) and hypertension (19.4%) were the most coexisting medical illnesses. About 12.9% of patients needed ICU care. Additionally, 16.1% of our patients died, which all of them were male.

Conclusion: This study showed a high prevalence of COVID-19 among our HD group, accompanied by mild symptoms. The HD population is probably among the most sensitive and high-risk groups for COVID-19 because of advanced age, comorbidities disease, low-immune function and frequent required visits, and patient overload in HD centers. Preventive measures should be taken in order to minimize the virus transmission in dialysis centers.


Implication for health policy/practice/research/medical education:

This study showed high prevalence of COVID-19 among hemodialysis (HD) group, accompanied by mild symptoms. The HD population is probably among the most sensitive and high-risk groups for COVID-19 because of advanced age, comorbidities disease, low-immune function and frequent required visits, and patient congestion in HD centers.

Please cite this paper as: Kenarkoohi A, Maleki M, Ghiasi B, Bastani E, Pakzad I, Bonyadi M, Abdoli A, Falahi S. Prevalence and clinical presentation of COVID-19 infection in hemodialysis patients. J Nephropathol. 2022;11(1):e07. DOI: 10.34172/jnp.2022.07.


First Name
Last Name
Email Address
Comments
Security code


Abstract View:

Your browser does not support the canvas element.

PDF Download:

Your browser does not support the canvas element.


Full Text View:

Your browser does not support the canvas element.